HEOTX
Price
$15.84
Change
-$0.48 (-2.94%)
Updated
Dec 18 closing price
RWIBX
Price
$62.66
Change
-$1.77 (-2.75%)
Updated
Dec 18 closing price
Ad is loading...

HEOTX vs RWIBX

Header iconHEOTX vs RWIBX Comparison
Open Charts HEOTX vs RWIBXBanner chart's image
Hartford Climate Opportunities R5
Price$15.84
Change-$0.48 (-2.94%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$62.66
Change-$1.77 (-2.75%)
VolumeN/A
CapitalizationN/A
HEOTX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HEOTX vs. RWIBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HEOTX is a Hold and RWIBX is a Buy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 121B vs. HEOTX (131M). RWIBX pays higher dividends than HEOTX: RWIBX (1.05) vs HEOTX (0.71). HEOTX was incepted earlier than RWIBX: HEOTX (9 years) vs RWIBX (23 years). HEOTX is a more actively managed with annual turnover of: 75.00 vs. RWIBX (27.00). HEOTX has a lower initial minimum investment than RWIBX: HEOTX (0) vs RWIBX (250). RWIBX (11.34) and HEOTX (10.97) have marching annual gain over last year. HEOTX return over 5 years is better than : 51.26 vs. RWIBX (29.64).
HEOTXRWIBXHEOTX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years23 years-
Gain YTD8.5119.78187%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets131M121B0%
Annual Yield % from dividends0.711.0568%
Returns for 1 year10.9711.3497%
Returns for 3 years1.568.4119%
Returns for 5 years51.2629.64173%
Returns for 10 yearsN/A44.22-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
NUVB2.810.12
+4.46%
Nuvation Bio
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics